I want to know the answer to the following question:
What was a recommendations brought about from the report?
All the background I'm provided with is that "Others have argued that excessive regulation suppresses therapeutic innovation, and that the current cost of regulator-required clinical trials prevents the full exploitation of new genetic and biological knowledge for the treatment of human disease.". Is that enough to answer the question?